| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 605 | 2023 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 85 | 2023 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 63 | 2023 |
| Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality N Moradian, M Gouravani, MA Salehi, A Heidari, M Shafeghat, ... European cytokine network 31, 81-93, 2020 | 50 | 2020 |
| Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, P Ye, M Tian, ... The Lancet Public Health 7 (8), e657-e669, 2022 | 36 | 2022 |
| How stable ischemic heart disease leads to acute coronary syndrome in COVID-19? M Shafeghat, A Aminorroaya, N Rezaei Acta Bio Medica: Atenei Parmensis 92 (5), 2021 | 13 | 2021 |
| Toll-like receptor 7 regulates cardiovascular diseases M Shafeghat, S Kazemian, A Aminorroaya, Z Aryan, N Rezaei International Immunopharmacology 113, 109390, 2022 | 12 | 2022 |
| The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study MR Malekpour, M Abbasi-Kangevari, SH Ghamari, J Khanali, ... EClinicalMedicine 60, 2023 | 6 | 2023 |
| The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease M Shafie, M Mayeli, S Saeidi, Z Mirsepassi, M Abbasi, M Shafeghat, ... Clinical Parkinsonism & Related Disorders 6, 100130, 2022 | 3 | 2022 |
| A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers AS Nasab, F Noorani, Z Paeizi, L Khani, S Banaei, M Sadeghi, ... International Journal of Alzheimer’s Disease 2023 (1), 3540020, 2023 | 2 | 2023 |
| Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study R Sharma, H Abbastabar, DM Abdulah, H Abidi, H Abolhassani, ... The Lancet Regional Health-Southeast Asia 21, 2024 | 1 | 2024 |
| Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019 S Moradi, A Parsaei, S Saeedi Moghaddam, A Aryannejad, ... Frontiers in public health 11, 1149719, 2023 | 1 | 2023 |
| A novel homozygous RAG1 mutation is associated with severe combined immunodeficiency and neurological presentations S Melika, E Hossein, S Mona, R Elham, Z Samaneh, S Sepideh, ... Allergologia et Immunopathologia 49 (4), 91-97, 2021 | 1 | 2021 |
| Relative Vortex Strength and Energetics Associate with Pulmonary Artery Pressure and Cardiac Function in Pulmonary Arterial Hypertension M Shafeghat, M Elbayumi, J Carr, MSM Elbaz Journal of Cardiovascular Magnetic Resonance 26, 2024 | | 2024 |
| Risk assessment for mortality in patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: A retrospective cohort study A Oraii, M Shafeghat, H Ashraf, A Soleimani, S Kazemian, A Sadatnaseri, ... Health Science Reports 7 (2), e1867, 2024 | | 2024 |
| Global Burden of Cardiovascular Diseases and Risks, 1990-2022 M George A, V Fuster, CJL Murray, GA Roth, GA Mensah, YH Abate, ... Elsevier, 2023 | | 2023 |
| Interdisciplinary Approach in Genitourinary Cancers M Shafeghat, M Balibegloo, N Rezaei | | 2022 |
| Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study M Montazeri, M Pazoki, A Hadadi, M Shafeghat, A Veisizadeh, ... Acta Medica Iranica, 413-417, 2022 | | 2022 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
